Clearance of cannabinoids during blood purification therapy for septic shock: A prospective observational study

Clearance of cannabinoids during blood purification therapy for septic shock: A prospective observational study - Clearance of cannabinoids during blood purification therapy for septic shock: A prospective observational study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032763

Enrollment

Registered

2018-06-01

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic shock

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo blood purification therapy with septic shock

Exclusion criteria

Exclusion criteria: Patients who are under 20 years old, those who didn't obtain informed consent, the cases with the estimated death within 24 hours and with the contraindication for anticoagulant use.

Design outcomes

Primary

Measure	Time frame
Clearance of various analytes at each measurement time	—

Secondary

Measure	Time frame
Changes in various analyte concentrations over time, the length of ICU stays, the period of ventilator days, 28-day survival rate, 60-day survival rate	—

Countries

Japan

Contacts

Public ContactYoshiki Masuda

Sapporo Medical University School of Medicine Department of Intensive Care Medicine

miminekko@me.com011-611-2111

Outcome results